Glassman Wealth Services’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-686
| Closed | -$34.7K | – | 977 |
|
|
2023
Q4 | $34.7K | Sell |
686
-53
| -7% | -$2.54K | ﹤0.01% | 546 |
|
|
2023
Q3 | $33.5K | Hold |
739
| – | – | 0.01% | 526 |
|
|
2023
Q2 | $30.3K | Buy |
739
+2
| +0.3% | +$77 | ﹤0.01% | 529 |
|
|
2023
Q1 | $26.3K | Buy |
737
+4
| +0.5% | +$150 | ﹤0.01% | 567 |
|
|
2022
Q4 | $27.7K | Sell |
733
-6
| -0.8% | -$252 | 0.01% | 574 |
|
|
2022
Q3 | $33K | Hold |
739
| – | – | 0.01% | 479 |
|
|
2022
Q2 | $27K | Sell |
739
-83
| -10% | -$3.13K | 0.01% | 543 |
|
|
2022
Q1 | $30K | Buy |
822
+399
| +94% | +$13.1K | 0.01% | 525 |
|
|
2021
Q4 | $13K | Sell |
423
-16
| -4% | -$504 | ﹤0.01% | 718 |
|
|
2021
Q3 | $15K | Buy |
439
+318
| +263% | +$12K | ﹤0.01% | 657 |
|
|
2021
Q2 | $5K | Sell |
121
-27
| -18% | -$1.06K | ﹤0.01% | 919 |
|
|
2021
Q1 | $7K | Hold |
148
| – | – | ﹤0.01% | 798 |
|
|
2020
Q4 | $8K | Sell |
148
-91
| -38% | -$4.54K | ﹤0.01% | 763 |
|
|
2020
Q3 | $11K | Buy |
239
+44
| +23% | +$2.44K | ﹤0.01% | 591 |
|
|
2020
Q2 | $11K | Buy |
195
+71
| +57% | +$3.95K | ﹤0.01% | 476 |
|
|
2020
Q1 | $6K | Sell |
124
-81
| -40% | -$4.51K | ﹤0.01% | 503 |
|
|
2019
Q4 | $12K | Hold |
205
| – | – | ﹤0.01% | 452 |
|
|
2019
Q3 | $12K | Buy |
205
+2
| +1% | +$130 | ﹤0.01% | 421 |
|
|
2019
Q2 | $13K | Buy |
203
+3
| +2% | +$212 | 0.01% | 419 |
|
|
2019
Q1 | $16K | Buy |
200
+100
| +100% | +$6.45K | 0.01% | 384 |
|
|
2018
Q4 | $5K | Hold |
100
| – | – | ﹤0.01% | 427 |
|
|
2018
Q3 | $5K | Hold |
100
| – | – | ﹤0.01% | 476 |
|
|
2018
Q2 | $4K | Hold |
100
| – | – | ﹤0.01% | 461 |
|
|
2018
Q1 | $4K | Hold |
100
| – | – | ﹤0.01% | 451 |
|
|
2017
Q4 | $5K | Hold |
100
| – | – | ﹤0.01% | 396 |
|
|
2017
Q3 | $5K | Hold |
100
| – | – | ﹤0.01% | 354 |
|
|
2017
Q2 | $5K | Hold |
100
| – | – | ﹤0.01% | 355 |
|
|
2017
Q1 | $4K | Sell |
100
-186
| -65% | -$8.35K | ﹤0.01% | 413 |
|
|
2016
Q4 | $14K | Buy |
286
+186
| +186% | +$7.36K | 0.01% | 312 |
|
|
2016
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 375 |
|
|
2016
Q2 | $2K | Hold |
100
| – | – | ﹤0.01% | 410 |
|
|
2016
Q1 | $4K | Hold |
100
| – | – | ﹤0.01% | 386 |
|
|
2015
Q4 | $6K | Hold |
100
| – | – | 0.01% | 360 |
|
|
2015
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 376 |
|
|
2015
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 369 |
|
|
2015
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 376 |
|
|
2014
Q4 | $6K | Buy |
+100
| New | +$4.93K | ﹤0.01% | 414 |
|
Other funds holding IONS
BG
Glassman Wealth Services's IONS Position: Q1 2024 in Review
Glassman Wealth Services sold out of Ionis Pharmaceuticals (IONS) in Q1 2024, closing a stake of 686 shares — an estimated $34.7K sold.
Glassman Wealth Services first reported a position in IONS in Q4 2014 and held it in 37 quarters. The position peaked at $34.7K in Q4 2023. 361 funds tracked by Wall St. Rank hold IONS as of Q1 2024.
- Glassman Wealth Services reported no remaining Ionis Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
- Glassman Wealth Services sold 686 Ionis Pharmaceuticals shares in Q1 2024, an estimated $34.7K.
- Glassman Wealth Services first reported a position in Ionis Pharmaceuticals in Q4 2014 and held it in 37 quarters.
- Glassman Wealth Services's Ionis Pharmaceuticals position peaked at $34.7K in Q4 2023.
- 361 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2024.
Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.